SIMULECT 20 mg, powder and solvent for solution for injection or infusion bottle, 5 ml
Active ingredients: Basiliximab
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Powder and solvent for solution for injection or infusionbottle, 5 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- SIMULECT 20 mg, poudre et solvant pour solution injectable ou pour perfusion
- Pharmaceutical form
- poudre et solvant pour solution injectable ou pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 1 flacon(s) en verre - ampoule(s) en verre de 5 ml
- Marketing authorisation holder
- NOVARTIS EUROPHARM (IRLANDE)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 2 Mar 1999
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68944294CIP75618928CIP133400956189281Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BASILIXIMABpoudre | 20 mg · un flacon | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The current BDPM data does not list similar medicines for this product.